Search results: Siglec-2
Product group Antibodies
Anti-CD200 [OX-2]Ab00549-8.1
ApplicationsFlow Cytometry
ReactivityRat
- SizePrice
Product group Antibodies
Anti-DLL4 [2-6]Ab02658-10.0
ApplicationsELISA, ImmunoHistoChemistry, Neutralisation/Blocking
ReactivityHuman
TargetDLL4
- SizePrice
Product group Antibodies
Anti-DLL4 [2-6]Ab02658-10.3
ApplicationsELISA, ImmunoHistoChemistry, Neutralisation/Blocking
ReactivityHuman
TargetDLL4
- SizePrice
Product group Antibodies
Anti-DLL4 [2-6]Ab02658-2.0
ApplicationsELISA, ImmunoHistoChemistry, Neutralisation/Blocking
ReactivityHuman
TargetDLL4
- SizePrice
Product group Antibodies
Anti-DLL4 [2-6]Ab02658-2.3
ApplicationsELISA, ImmunoHistoChemistry, Neutralisation/Blocking
ReactivityHuman
TargetDLL4
- SizePrice
Product group Antibodies
Anti-DLL4 [2-6]Ab02658-23.0
ApplicationsELISA, ImmunoHistoChemistry, Neutralisation/Blocking
ReactivityHuman
TargetDLL4
- SizePrice
Product group Antibodies
Anti-MVP [3F9-2]Ab02494-1.1
ApplicationsWestern Blot, ImmunoHistoChemistry
ReactivityVertebrate
- SizePrice
Product group Antibodies
Anti-MVP [3F9-2]Ab02494-23.0
ApplicationsWestern Blot, ImmunoHistoChemistry
ReactivityVertebrate
- SizePrice
Product group Antibodies
Anti-Integrin alpha 4 [HP1/2]Ab03253-1.1
ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
ReactivityGuinea Pig, Human
TargetITGA4
- SizePrice
Product group Antibodies
Anti-Integrin alpha 4 [HP1/2]Ab03253-10.0
ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
ReactivityGuinea Pig, Human
TargetITGA4
- SizePrice
Product group Antibodies
Anti-Integrin alpha 4 [HP1/2]Ab03253-10.3
ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
ReactivityGuinea Pig, Human
TargetITGA4
- SizePrice
Product group Antibodies
Anti-Integrin alpha 4 [HP1/2]Ab03253-23.0
ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
ReactivityGuinea Pig, Human
TargetITGA4
- SizePrice
Didn't find what you were looking for?
Search through our product groups to find the right product
Back to overview